Current Report Filing (8-k)
February 13 2023 - 4:12PM
Edgar (US Regulatory)
0001506983
false
0001506983
2023-02-07
2023-02-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 7, 2023
GLUCOTRACK,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
0-54785 |
|
98-0668934 |
(State or Other Jurisdiction |
|
(Commission |
|
(IRS Employer |
of Incorporation) |
|
File Number) |
|
Identification No.) |
8
Ariel Sharon Street, P.O. Box 6037607, Or Yehuda, Israel |
|
L3
7760049 |
(Address of principal executive
offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: 972 (8) 675-7878
N/A
(Former
name or former address, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock |
|
GCTK |
|
Nasdaq Capital Market |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
February 7, 2023, Nasdaq issued a letter to the Company granting an extension until May 22, 2023 to obtain compliance with the Listing
Rule 5550(b) (the “Rule”), which requires a minimum $2,500,000 stockholders’ equity, $35,000,000 market value of listed
securities, or $500,000 net income from continuing operations, notice of noncompliance with which was provided by Nasdaq to the Company
on November 22, 2022. Nasdaq has granted the Company an extension to comply through either one or both of an acquisition or equity
capital raise on or before May 22, 2023.
ITEM
9.01 Exhibit
Exhibit 104 |
|
Cover Page Interactive Data File (embedded within the
Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: February 13, 2023 |
|
|
|
|
GLUCOTRACK, INC. |
|
|
|
|
By: |
/s/ Jolie
Kahn |
|
Name: |
Jolie Kahn |
|
Title: |
Chief Financial Officer |
Integrity Applications (NASDAQ:IGAP)
Historical Stock Chart
From Dec 2024 to Jan 2025
Integrity Applications (NASDAQ:IGAP)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Integrity Applications Inc (NASDAQ): 0 recent articles
More Glucotrack, Inc. News Articles